Curcumin
Aug 07, 2018
Progenics got FDA Approval; Curcumin to cancer cells
Progenics got FDA Approval on Iobenguane I 131 for Rare Adrenal Gland Tumors A good news for unresectable rare adrenal tumor patients as oncologists now have a new treatment to offer . On July 30, 2018, the Food and Drug Administration approved Progenics Pharmaceuticals iobenguane I for adult and pediatric patient...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
